×

img Acces sibility Controls

Technologies Banner

All Technologies

One drop nasal vaccine based on flu vaccine candidate M2SR [CoroFlu]

Implementing Organization

About

Unique intranasal vaccine for Coronavirus ‘CoroFlu’ is under development. Bharat Biotech is manufacturing the vaccine, conduct clinical trials, and prepare to produce almost 300 million doses of vaccine for global distribution.
Funding Organization
Funding Organization

Quick Information
Focus Area
Development of nasal vaccine for COVID-19
Status
1
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
N/A
Startup (If Any)
00
No. of Patents
Filed :00
Grant :00
arrowtop